World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
57
Citations
11188
World Ranking
4351
National Ranking
132

Erwin A. van Vliet publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Erwin A. van Vliet sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 137 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Erwin A. van Vliet D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Erwin A. van Vliet sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 57 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Erwin A. van Vliet is affiliated with the University of Amsterdam in the Netherlands and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research predominantly focuses on neuroscience, epilepsy, and molecular mechanisms related to neurological disorders.

Their work encompasses several subfields of study, including molecular biology, physiology, cellular and molecular neuroscience, psychiatry and mental health, and pediatrics, perinatology, and child health. This diverse expertise reflects a broad approach to understanding neurological conditions at multiple biological levels.

Research topics covered by Erwin A. van Vliet include:

  • Neuroscience and neuropharmacology research
  • Epilepsy research and treatment
  • Pharmacological effects and toxicity studies
  • Tuberous sclerosis complex research
  • Metabolism and genetic disorders
  • Trace elements in health
  • MicroRNA in disease regulation

Among recent publications authored or co-authored by Erwin A. van Vliet, notable works include:

  • Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury, 2020, Neurobiology of Disease
  • Neurovascular unit dysfunction as a mechanism of seizures and epilepsy during aging, 2022, Epilepsia

Frequent co-authors in their body of work include:

  • Eleonora Aronica
  • James D. Mills
  • Diede W. M. Broekaart
  • Jan A. Gorter
  • Jasper J. Anink

They have published regularly in journals with a focus on neurological disorders and molecular science, including:

  • Epilepsia
  • International Journal of Molecular Sciences
  • Neuropathology and Applied Neurobiology
  • Experimental Neurology
  • Epilepsia Open

This scientist's research is concentrated on critical issues such as blood-brain barrier integrity, neuroinflammation following brain injury, and mechanisms contributing to epileptogenesis and seizure pathology. Their work also explores the role of neurovascular dysfunction in aging-related epilepsy, contributing to a detailed understanding of neurobiological disease processes.

Best Publications

  • Blood–brain barrier leakage may lead to progression of temporal lobe epilepsy

    E. A. van Vliet;S. da Costa Araújo;S. Redeker;R. van Schaik

  • Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons.

    J. A. Gorter;E. A. Van Vliet;E. Aronica;F. H. Lopes Da Silva

  • Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

    Unknown

  • Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy.

    Eleonora Aronica;Erwin A. Van Vliet;Oleg A. Mayboroda;Dirk Troost

  • Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe Epilepsy

    Jan A Gorter;Erwin A van Vliet;Eleonora Aronica;Timo Breit

  • Expression pattern of miR‐146a, an inflammation‐associated microRNA, in experimental and human temporal lobe epilepsy

    E. Aronica;K. Fluiter;A. Iyer;E. Zurolo

  • Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies

    E A van Vliet;E Aronica;A Vezzani;T Ravizza

  • Blood–brain barrier dysfunction, seizures and epilepsy

    E.A. van Vliet;E. Aronica;J.A. Gorter

  • Complement activation in experimental and human temporal lobe epilepsy.

    E. Aronica;K. Boer;E.A. van Vliet;S. Redeker

  • Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation

    Erwin A. van Vliet;Grazia Forte;Linda Holtman;Jeroen C. G. den Burger

  • Inhibition of the Multidrug Transporter P-Glycoprotein Improves Seizure Control in Phenytoin-treated Chronic Epileptic Rats

    Erwin A. Van Vliet;Rosalinde Van Schaik;Peter M. Edelbroek;Sandra Redeker

  • Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis

    Jan A. Gorter;Erwin A. van Vliet;Eleonora Aronica

  • Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy

    Alberto Pauletti;Gaetano Terrone;Tawfeeq Shekh-Ahmad;Alessia Salamone

  • Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain

    Eleonora Aronica;Jan A. Gorter;Sandra Redeker;Erwin A. Van Vliet

  • Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy

    Jan A. Gorter;Anand Iyer;Ian White;Anna Colzi

  • GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis.

    Cristina Roseti;Erwin A. van Vliet;Pierangelo Cifelli;Gabriele Ruffolo

  • COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats

    Erwin A. van Vliet;Guido Zibell;Anton Pekcec;Juli Schlichtiger

  • Neuronal cell death in a rat model for mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures.

    Jan A. Gorter;Pedro M. Gonçalves Pereira;Erwin A. Van Vliet;Eleonora Aronica

  • Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury

    Erwin A. van Vliet;Xavier Ekolle Ndode-Ekane;Lauri J. Lehto;Jan A. Gorter

  • Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation

    Erwin A. van Vliet;Eleonora Aronica;Else A. Tolner;Fernando H. Lopes da Silva

  • Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.

    Erwin A van Vliet;Eleonora Aronica;Sandra Redeker;Karin Boer

  • Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.

    Erwin A. van Vliet;Sandra Redeker;Eleonora Aronica;Peter M. Edelbroek

Frequent Co-Authors

Eleonora Aronica
Eleonora Aronica University of Amsterdam
Jan A. Gorter
Jan A. Gorter University of Amsterdam
Wytse J. Wadman
Wytse J. Wadman University of Amsterdam
Annamaria Vezzani
Annamaria Vezzani Mario Negri Institute for Pharmacological Research
Asla Pitkänen
Asla Pitkänen University of Eastern Finland
Floor E. Jansen
Floor E. Jansen Utrecht University
Peter C. van Rijen
Peter C. van Rijen Utrecht University
Dirk Troost
Dirk Troost University of Amsterdam
Maria Thom
Maria Thom University College London Hospitals NHS Foundation Trust
Heidrun Potschka
Heidrun Potschka Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Erwin A. van Vliet

Trending Scientists

Recently Published Articles